The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest neurodegenerative disorder therapeutics market share, and Middle East was the fastest-growing region in 2022.

The global neurodegenerative disorder therapeutics market is expected to grow from $15.86 billion in 2022 to $17.14 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The neurodegenerative disorder therapeutics market is expected to grow from $23.65 billion in 2027 at a CAGR of 8.4%.

Major Driver In The Neurodegenerative Disorder Therapeutics Market ­– Increase In The Prevalence Of Neurodegenerative Among The Global Population
According to World Population Prospects, the number of individuals over 60 will climb to 2.1 billion in 2050, while the number of persons over 80 will triple to 425 million. According to the Alzheimer’s Association, approximately 5.8 million Americans have Alzheimer’s disease, with the number expected to climb to approximately 14 million by 2050. The rising frequency of neurodegenerative illnesses among the ageing population drives the market for neurodegenerative disorder therapies.

View More On The Neurodegenerative Disorder Therapeutics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Key Neurodegenerative Disorder Therapeutics Market Segments
1) By Indication Type: Parkinson’s Disease, Alzheimer’s Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types
2) By Drug Type: N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, Other Drug Types
3) By Distribution: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Recent Neurodegenerative Disorder Therapeutics Market Trend – Strategic Partnerships With Government And Non-Government Organizations
Manufacturers of neurodegenerative disorder treatments are forming strategic alliances with government and non-government organisations in order to research and develop therapies for a variety of neurodegenerative disorders. Companies in the neurodegenerative disorder therapeutics market are also increasing their collaboration with other market participants in order to expand their capabilities for research and development activities in order to develop new and more effective therapeutic solutions to treat neurodegenerative disorders. NRG Therapeutics, a UK-based drug discovery firm focused on therapeutic methods, for example, teamed with Domainex, a UK-based drug discovery service, in July 2022, to create neurodegenerative disease treatment. The companies would collaborate to develop novel small molecule disease-modifying drugs for the treatment of Parkinson’s disease, motor neurone disease (MND), and other incapacitating chronic neurodegenerative disorders.

Neurodegenerative Disorder Therapeutics Market Prominent Players
Major players in the neurodegenerative disorder therapeutics market are Biogen, Pfizer, Novartis, Sanofi, Teva Pharmaceutical, UCB, Hoffmann- La Roche Ltd., ACADIA Pharmaceuticals Inc., Lundeck A/S, Boehringer Ingeiheim International GmbH, Merck Serono, Orion Pharma Ltd., Mitsubishi Tanabe Pharma America, Allergan, GlaxoSmith Kline PLC., AbbVie, Eli lilly, Celgene, Neuro- Hitech Inc., Bayer Schering Pharma AG, Amarin Corporation, AstraZeneca, Alector, Yumanity Therapeutics, Yangtze River Pharmaceutical Group, Chongqing Zein Pharmaceutical and Eisai.

Request A Sample Of The Global Neurodegenerative Disorder Therapeutics Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2818&type=smp

The Neurodegenerative Disorder Therapeutics Global Market Report 2023  provides a comprehensive overview on the neurodegenerative disorder therapeutics market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the neurodegenerative disorder therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Neurodegenerative disorder therapeutics are medications or gene therapies that are used to treat patients with neurodegenerative disorders by directly correcting pathogenic pathways via neuroprotection, neurorestoration, and symptom control.

View More Related Reports –
Oligonucleotide Therapy Global Market Report 2023
Generic Central Nervous System Drugs Global Market Report 2023
Neurostimulation Devices Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model